PreludeDx Appoints MiMi Reyes as Senior Executive Management Team to Support Growth Initiatives [Yahoo! Finance]
MDxHealth SA (MDXH)
Company Research
Source: Yahoo! Finance
cancer, today announced the appointment of MiMi Reyes as Senior Vice President of Operations. Reyes is a seasoned diagnostics and medical device executive with more than 25 years of experience and will oversee laboratory operations as PreludeDx continues to expand its technology, automation and capacity to meet accelerating demand. "I'm excited to join PreludeDx at an important time for the company," said Ms. Reyes. "PreludeDx has built a strong foundation in precision diagnostics, and I look forward to partnering across teams to further strengthen operations, innovation, and ensure the delivery of high-quality testing that positively impacts patients." Reyes is a results-driven, growth-focused executive who has led global molecular operations, and executed strategic growth initiatives in regulated U.S. and international environments. Her expertise includes managing laboratories compliant with CAP, CLIA, FDA, ISO 9001, and ISO 13485 standards, as well as building and leading high-
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA news events
Weekly update
A roundup of the hottest topics
MDXH
News
- MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences [Yahoo! Finance]Yahoo! Finance
- MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact SciencesGlobeNewswire
- MDxHealth announces next phase of collab with University of Oxford [Yahoo! Finance]Yahoo! Finance
- Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancerGlobeNewswire
- MDxHealth (NASDAQ:MDXH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.MarketBeat
MDXH
Earnings
- 11/12/25 - Miss
MDXH
Sec Filings
- 1/16/26 - Form SCHEDULE
- 1/12/26 - Form 6-K
- 12/29/25 - Form F-3
- MDXH's page on the SEC website